Contrast-enhanced Ultrasound of the Kidney

PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

July 9, 2018

Study Completion Date

July 9, 2018

Conditions
Chronic Kidney DiseaseCystic Kidney Disease
Interventions
DRUG

Perflutren lipid microsphere

Dosing per approved package label

Trial Locations (2)

37232

Vanderbilt University, Nashville

27599-7510

University of North Carolina of Chapel hill, Chapel Hill

All Listed Sponsors
collaborator

Vanderbilt University

OTHER

collaborator

North Carolina Translational and Clinical Sciences Institute

OTHER

lead

University of North Carolina, Chapel Hill

OTHER

NCT02684435 - Contrast-enhanced Ultrasound of the Kidney | Biotech Hunter | Biotech Hunter